| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.43B | 45.29B | 43.95B | 45.02B | 44.24B | 35.01B |
| Gross Profit | 5.46B | 6.47B | 5.40B | 5.30B | 6.09B | 5.42B |
| EBITDA | 5.30B | 6.31B | 5.23B | 4.94B | 5.57B | 4.63B |
| Net Income | 1.95B | 2.69B | 2.00B | 2.12B | 2.63B | 2.21B |
Balance Sheet | ||||||
| Total Assets | 45.42B | 46.26B | 44.54B | 44.27B | 42.48B | 38.79B |
| Cash, Cash Equivalents and Short-Term Investments | 9.98B | 10.72B | 9.73B | 9.49B | 8.18B | 7.99B |
| Total Debt | 5.92B | 4.35B | 4.52B | 4.90B | 3.84B | 3.86B |
| Total Liabilities | 18.99B | 17.05B | 18.02B | 18.99B | 20.15B | 19.20B |
| Stockholders Equity | 23.34B | 26.04B | 23.46B | 22.41B | 19.99B | 17.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.91B | 1.48B | 302.00M | 543.00M | -407.00M |
| Operating Cash Flow | 0.00 | 4.91B | 5.48B | 3.90B | 4.02B | 1.82B |
| Investing Cash Flow | 0.00 | -3.05B | -4.00B | -3.56B | -3.49B | -2.24B |
| Financing Cash Flow | 0.00 | -1.09B | -894.00M | 711.00M | -409.00M | -228.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥23.13B | 8.13 | ― | 2.87% | 3.04% | 38.35% | |
74 Outperform | ¥12.67B | 10.65 | ― | 4.93% | 1.21% | 13.37% | |
65 Neutral | ¥17.53B | 5.19 | ― | 4.33% | 2.56% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥10.47B | 39.24 | ― | 3.48% | 3.10% | -60.12% | |
54 Neutral | ¥11.06B | -4.86 | ― | ― | -3.09% | -68.39% | |
46 Neutral | ¥4.34B | -1.75 | ― | 1.06% | 8.16% | -1033.34% |